This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
20 Apr 2020

New agile solutions to accelerate digital supply chain transformation

New solutions will provide critical transparency to the life sciences supply chain, mobilizing companies to rapidly react to unforeseen disruptions and ensure medicine supply.

TraceLink, a leading digital platform company for the life sciences industry, has announced a new package of agile solutions designed to digitalize the pharmaceutical supply chain.

In response to COVID-19, TraceLink has "urgently" prioritized its focus on delivering solutions that will have an immediate impact in helping companies to meet unforeseen supply chain challenges and ensure the safe delivery of critical medicines and supplies to their patients.

Available on TraceLink’s Opus platform, the new agile solutions tap into TraceLink’s end-to-end network connectivity, data sharing, and multi-party process orchestration, giving companies the visibility and responsiveness needed for their supply chains to thrive in today’s challenging environment.

The centralized network-based system identifies, tracks and resolves supply partner issues in real-time. Agile Issue Management connects internal teams with external suppliers and downstream customers to manage unforeseen supply chain disruptions and resolve them faster.

When supply and demand experience massive fluctuation, drug shortages are inevitable. By leveraging the power of TraceLink’s network data and advanced analytics, TraceLink’s Drug Shortage Intelligence solution provides network-wide insights into supply and patient demand, allowing customers to accurately predict and prevent drug shortages, ensuring critical medicines are available to every patient.

By integrating Internet of Things with product serialization, this solution will provide full track and trace visibility for the secure delivery of vaccines, test kits and high-value products.

Related News